Home/ Supplements/ Carnitine/ Cohealon 333 mg

Cohealon 333 mg

product on market Tablet or Pill Cardiovascular Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Propionyl-L-Carnitine is researched for its potential to support nerve function and cognitive health. Current evidence for these specific effects is limited. The ingredient profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cohealon 333 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
90
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 500.0mg (861 products) 61 studies (A:4, B:13)

Other Ingredients

Microcrystalline Cellulose Stearic Acid Silicon Dioxide Dicalcium Phosphate L-Leucine Food Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Take one to three tablets daily, or as directed by a physician.

Formulation Notes

Cohealon is a scientifically designed dietary supplement which contains Propionyl-L-Carnitine, the physiologically active form of L-Carnitine. This product is specially formulated to provide a targeted delivery system.

Free of corn, yeast, wheat and gluten.

(Propionyl-L-Carnitine HCI)

Metadata

Product Details

UPC / SKU6 96859 13175 2
DSLD Entry Date2022-07-21
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID271242
Data Updated2026-04-11
Research

Research Evidence

80
Research Sources
49
Avg Quality
43
Rct
14
Clinical Trial
11
Systematic Review
9
Meta Analysis
2
Regulatory Source
A Propionyl-L-carnitine for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Carnitine supplements for people with chronic kidney disease requiring dialysis
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Acetyl-L-carnitine for patients with hepatic encephalopathy
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Carnitine for fatigue in multiple sclerosis
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
B L-carnitine for cognitive enhancement in people without cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Carnitine for fatigue in multiple sclerosis
Systematic Review The Cochrane database of systematic reviews 2010 PubMed DOI
B Systematic Review and Meta-analysis on Effect of Carnitine, Coenzyme Q10 and Selenium on Pregnancy and Semen Parameters in Couples With Idiopathic Male Infertility
Meta Analysis Urology 2022 PubMed DOI
B Effects of Carnitine and Coenzyme Q10 on Sperm Quality and Pregnancy Rates in Men with Unexplained Infertility: A Systematic Review and Network Meta-Analysis
Systematic Review Reproductive sciences (Thousand Oaks, Calif.) 2025 PubMed DOI
B Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis
Meta Analysis Nutrients 2017 PubMed DOI
View all evidence for Carnitine →
Compare

Similar Products

View all Carnitine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.